The Electron Transport System: Powering Cellular Life

Introduction

The Electron Transport System (ETS), also known as the electron transport chain (ETC), is a fundamental process in biology, acting as the central engine for energy conversion within living cells. This intricate series of protein complexes orchestrates a cascade of redox reactions, ultimately harnessing energy to generate an electrochemical gradient. This gradient is the driving force behind ATP synthase, an enzyme that produces adenosine triphosphate (ATP), the cell’s primary energy currency, through a process called oxidative phosphorylation.

This remarkable system is located in the mitochondria of eukaryotic cells, the powerhouses of the cell, and in the chloroplasts of plant cells, where it plays a crucial role in photosynthesis. In cellular respiration, the ETS extracts energy from nutrient molecules, breaking them down and transferring electrons along the chain. Conversely, in photosynthesis, light energy excites electrons, initiating their journey through a similar chain to fuel carbohydrate synthesis. Whether in respiration or photosynthesis, the electron transport system stands as a testament to nature’s elegant and efficient energy conversion mechanisms.

Fundamentals of the Electron Transport System

To understand the electron transport system, it’s crucial to place it within the broader context of cellular metabolism. Aerobic cellular respiration, the process by which cells extract energy from glucose and other organic fuels in the presence of oxygen, comprises three main stages:

1. Glycolysis: Glucose, a simple sugar, is broken down in the cytoplasm into two molecules of pyruvate. This initial step yields a small amount of ATP and the electron carrier molecule NADH (nicotinamide adenine dinucleotide).

2. Citric Acid Cycle (Krebs Cycle): Pyruvate is transported into the mitochondria and further processed. Each pyruvate molecule is converted into acetyl-CoA, generating more NADH, carbon dioxide (CO2), and a molecule of FADH2 (flavin adenine dinucleotide), another electron carrier. The citric acid cycle itself is a series of chemical reactions that further oxidize acetyl-CoA, releasing CO2, NADH, FADH2, and a small amount of ATP.

3. Oxidative Phosphorylation: This final stage, where the electron transport system plays a pivotal role, utilizes the NADH and FADH2 generated in the preceding steps. Oxidative phosphorylation consists of two tightly coupled components:

   • Electron Transport Chain (ETC): A series of protein complexes embedded in the inner mitochondrial membrane. Electrons from NADH and FADH2 are passed down this chain through a series of redox reactions, releasing energy in a controlled manner.
   • Chemiosmosis: The energy released by the electron transport chain is used to pump protons (H+) across the inner mitochondrial membrane, creating a proton gradient. This gradient stores potential energy, which is then harnessed by ATP synthase to drive the synthesis of large quantities of ATP.

Photosynthesis, the process by which plants and other organisms convert light energy into chemical energy, also relies on an electron transport system. In the light-dependent reactions of photosynthesis, light energy is absorbed by chlorophyll and used to split water molecules. This process releases electrons, protons, and oxygen (O2). The electrons are then passed through an electron transport chain in the thylakoid membranes of chloroplasts, generating a proton gradient that drives ATP synthesis. NADPH, another crucial electron carrier, is also produced in these light-dependent reactions. The ATP and NADPH generated during the light-dependent reactions are then used in the light-independent reactions (Calvin cycle) to fix carbon dioxide and synthesize sugars.

Image: A detailed illustration of the electron transport chain within the mitochondria, highlighting the flow of electrons, proton pumping, and ATP synthase activity.

The Electron Transport System at the Cellular Level

Within the inner mitochondrial membrane, the electron transport system is organized into four major protein complexes (Complex I to IV) and two mobile electron carriers (coenzyme Q and cytochrome c). Electrons are passed sequentially from one complex to the next, moving from molecules with lower reduction potential to those with higher reduction potential. This stepwise transfer of electrons releases energy at each step.

The energy released during electron transfer is primarily used to pump protons (H+) from the mitochondrial matrix (the space inside the inner membrane) into the intermembrane space (the space between the inner and outer mitochondrial membranes). This proton pumping creates an electrochemical gradient across the inner mitochondrial membrane, characterized by:

• A difference in pH: The intermembrane space becomes more acidic (higher H+ concentration) compared to the matrix.
• A difference in electrical potential: The intermembrane space becomes more positively charged relative to the matrix.

This proton gradient represents a form of stored energy, much like water held behind a dam. The potential energy stored in this gradient is then tapped by ATP synthase (Complex V) to synthesize ATP.

Here’s a closer look at the key components of the mitochondrial electron transport system:

• Complex I (NADH dehydrogenase): This complex is the entry point for electrons derived from NADH. It accepts electrons from NADH and transfers them to coenzyme Q. In this process, Complex I pumps four protons across the inner mitochondrial membrane.

• Complex II (Succinate dehydrogenase): Complex II provides an alternative entry point for electrons into the ETC. It accepts electrons from FADH2, which is generated during the citric acid cycle. Electrons are transferred from FADH2 to coenzyme Q. Importantly, Complex II does not pump protons across the membrane, resulting in slightly less ATP production when electrons enter the ETC via this complex.

  • Succinate + FAD → Fumarate + FADH2 + 2 H+ (matrix)
  • FADH2 + CoQ → FAD + CoQH2

• Coenzyme Q (Ubiquinone): This small, mobile molecule is a lipid-soluble electron carrier that shuttles electrons from both Complex I and Complex II to Complex III. Coenzyme Q undergoes reduction and oxidation in a cycle known as the Q cycle, playing a critical role in proton translocation.

• Complex III (Cytochrome bc1 complex): Complex III receives electrons from coenzyme Q and passes them to cytochrome c. This complex also pumps protons across the inner mitochondrial membrane, contributing to the proton gradient.

• Cytochrome c: Another mobile electron carrier, cytochrome c is a small protein that carries electrons from Complex III to Complex IV.

• Complex IV (Cytochrome c oxidase): The final complex in the electron transport system, Complex IV accepts electrons from cytochrome c and transfers them to the final electron acceptor, oxygen (O2). In this reaction, oxygen is reduced to water (H2O). Complex IV also pumps protons across the membrane, further enhancing the proton gradient.

• Complex V (ATP synthase): Although not directly involved in electron transport, ATP synthase is functionally linked to the ETS. It utilizes the proton gradient generated by Complexes I, III, and IV to synthesize ATP. Protons flow down their electrochemical gradient, from the intermembrane space back into the matrix, through a channel in ATP synthase. This flow of protons drives the rotation of a part of the enzyme, which in turn catalyzes the phosphorylation of ADP (adenosine diphosphate) to ATP. For every approximately 4 protons that pass through ATP synthase, one molecule of ATP is produced. Intriguingly, ATP synthase can also operate in reverse, using ATP hydrolysis to pump protons against their gradient, although this is less common in typical cellular conditions.

Molecular Players in the Electron Transport System

Understanding the molecular details of the electron transport system reveals the elegant chemistry that underlies cellular energy production. Key molecules like NADH and FADH2 are central to this process.

Nicotinamide Adenine Dinucleotide (NAD+/NADH): NAD+ and its reduced form, NADH, are crucial dinucleotides involved in redox reactions throughout metabolism. NAD+ acts as an oxidizing agent, accepting electrons and becoming reduced to NADH. NADH then carries these high-energy electrons to Complex I of the electron transport system.

• Reaction 1: RH2 + NAD+ → R + NADH + H+ (RH2 represents a reduced substrate, R is the oxidized substrate)

When NADH donates its electrons to Complex I, it is oxidized back to NAD+, releasing protons and electrons:

• Reaction 2: NADH → NAD+ + H+ + 2 e-

Electrons from NADH, entering at Complex I, contribute to the pumping of a total of 10 protons across the inner mitochondrial membrane (4 from Complex I, 4 from Complex III, and 2 from Complex IV). Since approximately 4 protons are required to synthesize 1 ATP by ATP synthase, each NADH molecule theoretically yields about 2.5 ATP molecules (some sources round this to 3 ATP).

Flavin Adenine Dinucleotide (FAD/FADH2): FAD and its reduced form, FADH2, are another pair of redox-active molecules. FAD is composed of an adenine nucleotide and flavin mononucleotide (FMN). FADH2 is generated in reactions like the citric acid cycle and fatty acid oxidation. FADH2 enters the electron transport system at Complex II, donating its electrons to coenzyme Q.

• Reaction 3: FADH2 → FAD + 2 H+ + 2 e-

Electrons from FADH2, entering at Complex II, bypass Complex I and lead to the pumping of fewer protons (4 from Complex III and 2 from Complex IV, totaling 6 protons). Consequently, each FADH2 molecule yields approximately 1.5 ATP molecules (some sources round this to 2 ATP).

Beyond its role in the ETS, FAD is involved in various other metabolic pathways, including DNA repair, fatty acid metabolism, and the synthesis of essential coenzymes.

Clinical Significance of the Electron Transport System

The electron transport system is not only a fundamental biological process but also a critical target for various toxins and a site of dysfunction in several diseases.

Uncoupling Agents: These substances disrupt the tight coupling between electron transport and ATP synthesis. Uncouplers increase the permeability of the inner mitochondrial membrane to protons. This allows protons to leak back into the mitochondrial matrix without passing through ATP synthase. While electron transport continues, the proton gradient is dissipated, and ATP synthesis is reduced or abolished. The energy released by electron transport is then dissipated as heat.

• Aspirin (Salicylic Acid): In high doses, aspirin can act as an uncoupling agent.
• Thermogenin: This protein, found in brown adipose tissue, is a natural uncoupling agent. It facilitates proton leak across the inner mitochondrial membrane, generating heat instead of ATP. This is a key mechanism for non-shivering thermogenesis, particularly important in newborns and hibernating animals.

Uncoupling agents lead to a paradoxical situation: the body attempts to increase electron transport to compensate for reduced ATP production, leading to increased oxygen consumption and heat generation. This can result in hyperthermia and metabolic disturbances, including lactic acidosis due to increased anaerobic metabolism as cells struggle to produce ATP.

Oxidative Phosphorylation Inhibitors: A range of toxins can directly inhibit specific components of the electron transport system, blocking electron flow and ATP synthesis. These inhibitors can have severe and potentially lethal consequences.

• Complex I Inhibitors:

  • Rotenone: A natural insecticide and piscicide, rotenone inhibits electron transfer from Complex I to coenzyme Q.
  • Barbiturates (some): Certain barbiturates can also inhibit Complex I.

• Complex II Inhibitors:

  • Carboxin: A fungicide that inhibits Complex II by interfering with ubiquinone binding.

• Complex III Inhibitors:

  • Antimycin A: An antibiotic and piscicide, antimycin A blocks electron transfer at Complex III.

• Complex IV Inhibitors:

  • Cyanide (CN-): A highly potent and rapidly acting poison, cyanide binds to cytochrome c oxidase (Complex IV), preventing it from accepting electrons. This effectively shuts down the entire electron transport system. Cyanide poisoning can result from exposure to smoke from fires, industrial chemicals, and certain seeds. Symptoms include rapid onset of tissue hypoxia, almond-like breath odor, and unresponsiveness to supplemental oxygen. Treatment involves using nitrites to create methemoglobin, which binds cyanide, and thiosulfate or hydroxocobalamin to detoxify cyanide.
  • Carbon Monoxide (CO): Carbon monoxide, a colorless, odorless gas produced by incomplete combustion, also inhibits Complex IV by binding to cytochrome c oxidase. CO poisoning is a significant cause of accidental and intentional deaths. Symptoms are similar to cyanide poisoning, reflecting tissue hypoxia. Treatment involves administering high concentrations of oxygen.

• ATP Synthase Inhibitors:

  • Oligomycin: This antibiotic inhibits ATP synthase by blocking the proton channel (F0 subunit), preventing proton flow and ATP synthesis.

Understanding the electron transport system and its vulnerabilities is crucial not only for comprehending fundamental biology but also for addressing clinical conditions related to mitochondrial dysfunction and poisoning.

Review Questions

(Note: Review questions from the original article were removed as per instructions to only include title and content.)

References

(References remain as in the original article)

1.Lencina AM, Franza T, Sullivan MJ, Ulett GC, Ipe DS, Gaudu P, Gennis RB, Schurig-Briccio LA. Type 2 NADH Dehydrogenase Is the Only Point of Entry for Electrons into the Streptococcus agalactiae Respiratory Chain and Is a Potential Drug Target. mBio. 2018 Jul 03;9(4) [PMC free article: PMC6030563] [PubMed: 29970468]

2.Hirst J. Towards the molecular mechanism of respiratory complex I. Biochem J. 2009 Dec 23;425(2):327-39. [PubMed: 20025615]

3.Sazanov LA, Hinchliffe P. Structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus. Science. 2006 Mar 10;311(5766):1430-6. [PubMed: 16469879]

4.Hirst J. Energy transduction by respiratory complex I–an evaluation of current knowledge. Biochem Soc Trans. 2005 Jun;33(Pt 3):525-9. [PubMed: 15916556]

5.Yankovskaya V, Horsefield R, Törnroth S, Luna-Chavez C, Miyoshi H, Léger C, Byrne B, Cecchini G, Iwata S. Architecture of succinate dehydrogenase and reactive oxygen species generation. Science. 2003 Jan 31;299(5607):700-4. [PubMed: 12560550]

6.Horsefield R, Iwata S, Byrne B. Complex II from a structural perspective. Curr Protein Pept Sci. 2004 Apr;5(2):107-18. [PubMed: 15078221]

7.Geertman JM, van Maris AJ, van Dijken JP, Pronk JT. Physiological and genetic engineering of cytosolic redox metabolism in Saccharomyces cerevisiae for improved glycerol production. Metab Eng. 2006 Nov;8(6):532-42. [PubMed: 16891140]

8.Thorpe C, Kim JJ. Structure and mechanism of action of the acyl-CoA dehydrogenases. FASEB J. 1995 Jun;9(9):718-25. [PubMed: 7601336]

9.Sun C, Benlekbir S, Venkatakrishnan P, Wang Y, Hong S, Hosler J, Tajkhorshid E, Rubinstein JL, Gennis RB. Structure of the alternative complex III in a supercomplex with cytochrome oxidase. Nature. 2018 May;557(7703):123-126. [PMC free article: PMC6004266] [PubMed: 29695868]

10.Iwata S, Lee JW, Okada K, Lee JK, Iwata M, Rasmussen B, Link TA, Ramaswamy S, Jap BK. Complete structure of the 11-subunit bovine mitochondrial cytochrome bc1 complex. Science. 1998 Jul 03;281(5373):64-71. [PubMed: 9651245]

11.Trumpower BL. The protonmotive Q cycle. Energy transduction by coupling of proton translocation to electron transfer by the cytochrome bc1 complex. J Biol Chem. 1990 Jul 15;265(20):11409-12. [PubMed: 2164001]

12.Hunte C, Palsdottir H, Trumpower BL. Protonmotive pathways and mechanisms in the cytochrome bc1 complex. FEBS Lett. 2003 Jun 12;545(1):39-46. [PubMed: 12788490]

13.Calhoun MW, Thomas JW, Gennis RB. The cytochrome oxidase superfamily of redox-driven proton pumps. Trends Biochem Sci. 1994 Aug;19(8):325-30. [PubMed: 7940677]

14.Schmidt-Rohr K. Oxygen Is the High-Energy Molecule Powering Complex Multicellular Life: Fundamental Corrections to Traditional Bioenergetics. ACS Omega. 2020 Feb 11;5(5):2221-2233. [PMC free article: PMC7016920] [PubMed: 32064383]

15.Lovero D, Giordano L, Marsano RM, Sanchez-Martinez A, Boukhatmi H, Drechsler M, Oliva M, Whitworth AJ, Porcelli D, Caggese C. Characterization of Drosophila ATPsynC mutants as a new model of mitochondrial ATP synthase disorders. PLoS One. 2018;13(8):e0201811. [PMC free article: PMC6086398] [PubMed: 30096161]

16.Okuno D, Iino R, Noji H. Rotation and structure of FoF1-ATP synthase. J Biochem. 2011 Jun;149(6):655-64. [PubMed: 21524994]

17.Junge W, Nelson N. ATP synthase. Annu Rev Biochem. 2015;84:631-57. [PubMed: 25839341]

18.Hinkle PC. P/O ratios of mitochondrial oxidative phosphorylation. Biochim Biophys Acta. 2005 Jan 07;1706(1-2):1-11. [PubMed: 15620362]

19.Barrett MA, Zheng S, Roshankar G, Alsop RJ, Belanger RK, Huynh C, Kučerka N, Rheinstädter MC. Interaction of aspirin (acetylsalicylic acid) with lipid membranes. PLoS One. 2012;7(4):e34357. [PMC free article: PMC3328472] [PubMed: 22529913]

20.Warrick BJ, King A, Smolinske S, Thomas R, Aaron C. A 29-year analysis of acute peak salicylate concentrations in fatalities reported to United States poison centers. Clin Toxicol (Phila). 2018 Sep;56(9):846-851. [PubMed: 29431532]

21.Cinti S. The adipose organ. Prostaglandins Leukot Essent Fatty Acids. 2005 Jul;73(1):9-15. [PubMed: 15936182]

22.Enerbäck S. The origins of brown adipose tissue. N Engl J Med. 2009 May 07;360(19):2021-3. [PubMed: 19420373]

23.Zhou W, Faraldo-Gómez JD. Membrane plasticity facilitates recognition of the inhibitor oligomycin by the mitochondrial ATP synthase rotor. Biochim Biophys Acta Bioenerg. 2018 Sep;1859(9):789-796. [PMC free article: PMC6176861] [PubMed: 29630891]

24.Kamalian L, Douglas O, Jolly CE, Snoeys J, Simic D, Monshouwer M, Williams DP, Kevin Park B, Chadwick AE. The utility of HepaRG cells for bioenergetic investigation and detection of drug-induced mitochondrial toxicity. Toxicol In Vitro. 2018 Dec;53:136-147. [PubMed: 30096366]

25.Wood DM, Alsahaf H, Streete P, Dargan PI, Jones AL. Fatality after deliberate ingestion of the pesticide rotenone: a case report. Crit Care. 2005 Jun;9(3):R280-4. [PMC free article: PMC1175899] [PubMed: 15987402]

26.Lupescu A, Jilani K, Zbidah M, Lang F. Induction of apoptotic erythrocyte death by rotenone. Toxicology. 2012 Oct 28;300(3):132-7. [PubMed: 22727881]

27.Wallace KB. Doxorubicin-induced cardiac mitochondrionopathy. Pharmacol Toxicol. 2003 Sep;93(3):105-15. [PubMed: 12969434]

28.Weaver LK. Clinical practice. Carbon monoxide poisoning. N Engl J Med. 2009 Mar 19;360(12):1217-25. [PubMed: 19297574]

29.Sato K, Tamaki K, Hattori H, Moore CM, Tsutsumi H, Okajima H, Katsumata Y. Determination of total hemoglobin in forensic blood samples with special reference to carboxyhemoglobin analysis. Forensic Sci Int. 1990 Nov;48(1):89-96. [PubMed: 2279722]

30.Barker SJ, Tremper KK. The effect of carbon monoxide inhalation on pulse oximetry and transcutaneous PO2. Anesthesiology. 1987 May;66(5):677-9. [PubMed: 3578881]

31.Raub JA, Mathieu-Nolf M, Hampson NB, Thom SR. Carbon monoxide poisoning–a public health perspective. Toxicology. 2000 Apr 07;145(1):1-14. [PubMed: 10771127]

32.Jensen P, Wilson MT, Aasa R, Malmström BG. Cyanide inhibition of cytochrome c oxidase. A rapid-freeze e.p.r. investigation. Biochem J. 1984 Dec 15;224(3):829-37. [PMC free article: PMC1144519] [PubMed: 6098268]

33.Shchepina LA, Pletjushkina OY, Avetisyan AV, Bakeeva LE, Fetisova EK, Izyumov DS, Saprunova VB, Vyssokikh MY, Chernyak BV, Skulachev VP. Oligomycin, inhibitor of the F0 part of H+-ATP-synthase, suppresses the TNF-induced apoptosis. Oncogene. 2002 Nov 21;21(53):8149-57. [PubMed: 12444550]

Disclosures:

Disclosure: Maria Ahmad declares no relevant financial relationships with ineligible companies.

Disclosure: Adam Wolberg declares no relevant financial relationships with ineligible companies.

Disclosure: Chadi Kahwaji declares no relevant financial relationships with ineligible companies.